Page 140 - Genentech News Today

By Ben Glickman Shares of Genprex were higher early Wednesday after the company said it had received Fast Track Designation from the U.S. Food and Drug...

/PRNewswire/ -- DelveInsights Geographic Atrophy Market Insights report includes a comprehensive understanding of current treatment practices, geographic...

The runway show, which features people living with SMA as well as clothing designs informed by members of the community, will be held at the Cure SMA’s annual SMA Conference in Orlando on Thursday.

Career-focused high school programs, like the one at TIDE Academy in Menlo Park, are preparing students for college and the workforce, a San Mateo Civil Grand Jury report said. But there are roadblocks to widening access to them.

AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease Ongoing Phase 1b/2 ABATE study enrolling well and expanding to sites in USA with Investigational New Drug (IND) clearance for ACI-24.060Dosed first individual with Down syndrome (DS) in the DS cohort of ABATEInterim safety and immunogenicity data in Alzheimer’s disease (AD) and DS cohorts expected in H2 2023Initial PET data on amyloid plaque reduction i...

/PRNewswire/ -- The "Global Breast Cancer Immunotherapy Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.coms offering....

The FDA is expected to grant full approval to Leqembi, an Alzheimer’s drug from Eisai and Biogen.

Aliso Veijo, California (PRWEB) June 27, 2023 -- Members of the rare disease community from around the world will gather in San Diego in September for Global

Flywheel, which helps enterprises put medical imaging data in order for AI, today announced $54 million in series D funding.

PagerDuty receives highest possible score in adoption criterion and “goes beyond alerting to automate processes and workflows that accelerate resolutions” according to report